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Private investments in research are a hot topic in the European Union(EU). Interest has increased due to the targets set in Barcelona 2002 to
implement the EU 2000 Lisbon treaty, and were recently renewed.1 The
targets concern an overall investment in research and development
(R&D) of 3% of their Gross Domestic Product (GDP); two-thirds of
this should be private investments. In 2000, the EU countries spent
only 1.82% of their GDP on R&D, with only a slight majority coming
from private investments. By setting the targets, the EU expected to
reinforce the competitiveness of its economy compared to e.g. the USA
and Japan who indeed invested about 3% of their GDP in R&D. Recent
figures have not been impressive, with an average total investment in
R&D of EU countries being 1.9% of their GDP in 2010. However, the
EU continues to aim at 3% in its new plan Europe 2020.1
Public–private partnerships (PPP) are a way to realize such an increase
in R&D investments, with the joint financing and performance of projects
by the public and private sector.2 Behind lies the idea that the private
sector knows the market and the appropriate ways to invest and make
profits out of investments, and that government has insight in and
represents societal needs.
There is evidence of both pros and cons of PPP. To jump to the con-
clusion: PPP with for-profit partners may work in health research if
profits on investment can be made at least theoretically. If not, then do
not expect them to work, except for not-for-profit private partners. In all
cases, PPP require full transparency regarding conflicts of interest and
independence of research.
Prerequisites for PPP: potential profits
and societal needs
Companies basically aim at profits on investments; even though other
aims like transparency and sustainability are at stake as well. For
companies, R&D activities in PPP should yield products that allow for
a feasible profit scheme. Pharmaceutical R&D can for instance lead to
profits by the mechanism of patenting. Similar mechanisms apply for
diagnostic devices, (home)care technology, communication tools, etc.
Government represents the societal needs in PPP. Regarding health
research, these in particular concern the promotion and protection of
public health, but other societal needs may prevail too, like economic
growth and sustainability.1 Public health needs that can be translated to
PPP are e.g. the development of priority medicines, vaccines and
screening technologies. Regarding these topics, PPP may provide a
good framework for R&D: patenting provides a potential means for
companies to make profits, and public needs are apparent. However,
for other public health needs, PPP with for-profit companies are
unlikely to lead to a successful project. This for example applies for be-
havioural interventions aiming at reduction of obesity or of childhood
behavioural problems. Regarding these topics, a profitable scheme is not
available: patenting is unlikely, and it is difficult to set a monopoly on
new evidence as obtained.
The lack of a usable for-profit scheme in many public health interven-
tions may not always set a blockade against any PPP. First, not the entire
private sector is for-profit: many trusts and other not-for-profit
organizations also finance health research and may participate in PPP.
Moreover, PPP may also yield effects for the general public relations and
branding of companies that are restricted to those companies, even
though not patentable. In these instances, many of the above remarks
on the feasibility of PPP in public health do not apply.
Viability of PPP in public health research
The above examples show that PPP can be a means to support R&D in
public health under specific conditions. It is then up to the public
partners and the researchers involved to maintain a reasonable balance
between private investments and private profits. Equally important is it
for researchers to keep sufficient independence. Regarding pharmaceut-
ical R&D there is an extensive database on the risks for researchers of
becoming too dependent on private financing,3 and this equally applies to
any PPP construction.
Some other risks of particular relevance to public health should be
acknowledged: the first is ‘crowding out’. PPP may be so attractive for
researchers that many of them focus on the topics entered by PPP that are
inherently market-driven. That may lead to a lack of work force to
address challenges that address societal needs that can not be translated
in profitable business.2 Second, PPP in any sector, inside or outside the
health sector, may lead to products and developments that yield potential
risks for public health, or at least raise public concerns. A typical example
of this is the possible health threats of genetically modified crops. Public
responses to such suspected threats require monitoring activities, which
typically will be paid by public funds that might have been better needed
for other investments.
The use of PPP in public health requires innovative solutions. An
example of this is the branding of behavioural interventions by using a
specific label and a rigid quality assurance system, and then asking re-
muneration for their use. This may enable to invest in an R&D trajectory,
like has occurred for the Triple P family of parenting interventions
(www1.triplep.net).4 Moreover, monitoring of the risks for public
health could be a compulsory part of any PPP. And finally, both
journals and researchers should aim at maximum transparency.
In short: PPP may provide additional means for public health research,
even in the current economic crisis. However, the balance of gains and
losses due to PPP is certainly not clear-cut positive for public health.
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There is wealth of literature on social determinants of health. Themechanisms through which social determinants influence health and
health inequities are multiple. Many agree that health behaviours are in
key position. In populations with marked social characterization of health
behaviours, smoking, alcohol use, food habits and physical activity count
for much of mortality differences between socioeconomic groups.1
Although there is a lot of cross sectional data, there is relatively little
research how social changes in a population are reflected in health
behaviours within the same population and its subgroups.
Health behaviours are relatively stable; people follow—under social,
economic and cultural constraints—behavioural patterns adapted in
childhood and youth. However, the many intervention and monitoring
studies show that population-wide behavioural changes are possible.2,3
But what can be learned about change and stability of health behaviours
when time trends and socio-demographic differences are compared in
different countries? A relevant report was recently published on health
behaviours in North-Eastern Europe, in Estonia, Finland, Latvia and
Lithuania in 1998–2008. This Finbalt Health Monitor report gives inter-
esting lessons on the dynamics of social determinants of health
behaviours.4
During the last decade Finland and the Baltic countries have gone
through economic growth, increase in material living standard and
stronger identification with Western European economies. However,
the social changes and economic growth started much earlier in
Finland, while the Baltic countries came out from the communist
period only in early 1990’s. Finland joined the European Union 10
years earlier than the Baltic countries. During the period of the study,
1998–2008, Finland started generally from a healthier situation and in
the follow-up positive, although not dramatic changes took place,
while changes in health behaviour in the Baltic countries were more
pronounced.
The examples show how men in Finland smoke less than men in
Estonia, Latvia or Lithuania, but smoking has decreased more rapidly
in the Baltic countries than in Finland. Ten years ago, eating habits in
Finland were healthier than in the Baltic countries, but since then, the
Baltic countries have begun to catch up, especially with increased con-
sumption of vegetables. In Finland risky traffic behaviours were less
common than in the Baltic countries but remarkable increase in
reflector and seat belt use took place in Latvia and Estonia. As a conse-
quence, the national differences in risky traffic behaviours either dis-
appeared or diminished.
The positive changes in the Baltic countries reflect broad social
change in the health determinants, but many were due to legislative
actions and health promotion programmes in support of policy
reforms. They demonstrate how policy interventions can affect health
behaviour.
Socio-demographic differences in health behaviours seemed to be
persistent and similar in the four countries. For example, women tend
to eat vegetables more frequently and use vegetable oils, while men
eat more meat products. People with higher educational level have
consistently healthier food habits than those with lower educational
level. Alcohol consumption has increased more among the lower educa-
tional groups. People with a low education level still smoke more and
are more often exposed to tobacco smoke than those with a higher
education level.
Social, economic and political changes in a nation are reflected in
health behaviour of the populations. Faster structural changes lead to
faster changes in health behaviour, and these changes can be either
beneficial or harmful in terms of public health. Gender and
socio-economic differences in health behaviours on the other hand
seem to be surprisingly persistent even during political and economic
turmoil.
This experience underlines the importance of national and internation-
al health monitoring recommended by the WHO report on Social
Determinants of Health. Monitoring systems are essential for knowing
the magnitude of the public health problems, understanding who are
most affected and whether the situation is improving or deteriorating
over time.5 Such monitoring should, indeed, include health behaviours
and their social determinants.
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